ArticleKorean journal of ophthalmology : KJO2026
Clinical Outcomes after Bilateral Mix-and-Match Implantation of Extended Depth of Focus and Trifocal Intraocular Lenses.
Article in Korean journal of ophthalmology : KJO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mixing and matching Lucidis extended depth of focus intraocular lenses with other eyes being phakic or having monofocal intraocular lenses.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo evaluate the clinical outcomes after bilateral mix-and-match implantation of extended depth of focus (EDOF) and trifocal intraocular lenses (IOLs).
methodsA total of 134 eyes of 67 patients who had met all inclusion and exclusion criteria and underwent bilateral cataract surgery were included. The Symfony or Symfony toric EDOF IOL (Johnson & Johnson Vision Care Inc.) was implanted in the dominant eye, and the PanOptix or PanOptix toric trifocal IOL (Alcon Laboratories Inc.) in the nondominant eye. The uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), corrected distance visual acuity (CDVA), defocus curve, contrast sensitivity, and satisfaction questionnaire were obtained preoperatively and at 1, 6, and 12 months after surgery.
resultsAt 12 months after surgery, the mean UDVA (logMAR) was 0.03 ± 0.06 in the EDOF IOL-implanted eyes, 0.07 ± 0.11 in the trifocal IOL-implanted eyes, and 0.02 ± 0.06 in both eyes. The mean UIVA was 0.08 ± 0.08 in EDOF IOL-implanted eyes, 0.09 ± 0.11 in trifocal IOL-implanted eyes, and 0.03 ± 0.08 in both eyes. Mean UNVA was 0.51 ± 0.26 in EDOF IOL-implanted eyes, 0.22 ± 0.16 in trifocal IOL-implanted eyes, and 0.17 ± 0.12 in both eyes. Overall satisfaction rates were 43.3%, 41.1%, and 38.5% at 1, 6, and 12 months, respectively, while more than 70% of patients consistently reported that they would recommend the surgery to others. The most common causes of dissatisfaction were dry eye symptoms and reduced near vision.
conclusionsBilateral mix-and-match implantation of EDOF and trifocal IOL implantation showed good visual outcomes for distance, intermediate, and near vision until 12 months. Most patients satisfied with visual quality, but more dissatisfied with dry eye disease and poor near vision than photopic phenomena like glare and halos.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.